07.09.2010
- Glaxosmithkline will not step in as a rival bidder for U.S. biotech Genzyme and take on Sanofi-Aventis, the British drugmaker's head of research and development told a French...
06.09.2010
- French drugmaker Sanofi-Aventis would be prepared to moderately raise its $69 per share offer for Genzyme if the U.S. biotech agreed to negotiate, Dow Jones reported, citing a...
02.09.2010
- U.S. biotech Genzyme, which has rejected an $18.5 billion offer from French drugmaker Sanofi-Aventis, appears to hold the upper hand in the takeover struggle, according to Geoffrey...
02.09.2010
- French oil company Total has received offers for its UK Lindsey refinery and hopes to sell it by the end of the year, Chief Executive Officer Christophe de Margerie, said on...
31.08.2010
- U.S. biotech company Genzyme rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis on Monday, setting the stage for a protracted and potentially hostile...
30.08.2010
- France's Sanofi-Aventis on Sunday publicly disclosed its $18.5 billion, $69-per-share cash offer for Genzyme in a bid to rouse shareholders after failing to engage the U.S...
26.08.2010
- Sanofi-Aventis shareholders L'oreal and Total worry that the French drugmaker will pay too much for U.S. biotech company Genzyme and are not convinced it is the best fit, bankers...
26.08.2010
- Sanofi-Aventis is not willing to pay more than $70 per share for U.S. biotech Genzyme and may look at alternative targets, Bloomberg reported on Wednesday, citing sources familiar...
19.08.2010
- A senior Johnson & Johnson pharmaceuticals executive will now also oversee the company's consumer healthcare unit, following quality control lapses that led to massive recalls of...
13.08.2010
- Looking back, moving forward - The fine chemical industry has gone through a few difficult periods in the last decennium. More recently, however, the market has improved quite a...
